New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders (Q35739671)
Jump to navigation
Jump to search
scientific article published on 25 January 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders |
scientific article published on 25 January 2012 |
Statements
1 reference
7 references
New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders (English)
1 reference
7 references
Ola E Dahl
1 reference
25 January 2012
8 references
22 March 2019
17 June 2019
17 September 2019
2 October 2019
19 November 2019
28 January 2021
2 February 2021
8 references
22 March 2019
17 June 2019
17 September 2019
2 October 2019
19 November 2019
28 January 2021
2 February 2021
8
1 reference
45-57
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference